Kyle K. Millage
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kyle K. Millage has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Gene E. McClellan
3 shared publications- Bahman Asgharian
Applied Research Associates, Arlington Division, Raleigh, NC, USA
2 shared publications Gene McClellan
Applied Research Associates, Inc., Arlington, VA
2 shared publicationsJosh Bergman
Applied Research Associates, Inc., Arlington, VA
2 shared publicationsBahman Asgharian
Applied Research Associates, Inc., Arlington, VA
1 shared publication- Daniela Stricklin
Applied Research Associates, Inc., Arlington, VA, USA
1 shared publication
Latest Publications
- Open Access
- 1 September 2015
- Published by Defense Technical Information Center (DTIC)
Medical Modeling of Particle Size Effects for CB Inhalation Hazards
In this project, Applied Research Associates, Inc. (ARA) developed the Deposition And Response in the Respiratory Tract (DARRT) model; an improved medical model of particle size effects for inhalation hazards from chemical and biological (CB) agents. This project was initiated to improve modeling of the variation in human response caused by differences in particle sizes, in particular, for coarse particles that may be present near a dissemination source and may remain suspended long enough in an urban environment to expose large numbers of people. Plume dispersion calculations with the Defense Threat Reduction Agency's (DTRA's) Hazard Prediction and Assessment Capability (HPAC) show that, contrary to common beliefs, particles as large as 20 to 40 microns in diameter can be a significant hazard tens of kilometers downwind of a release. DARRT predicts the probability of infection or injury from inhalation exposure to aerosol hazards of CB agents with aerodynamic diameters between 0.01 and 100 microns and describes the resulting medical impact. Many current models assume that only the 1 to 5 micron respirable particles capable of reaching the pulmonary region of the respiratory system are of concern; however, we find that inclusion of coarse (greater than 5 micron) particle deposition is important, as well.
- 1 September 2015
- Published by Defense Technical Information Center (DTIC)
Open AccessMedical Modeling of Particle Size Effects for CB Inhalation Hazards
In this project, Applied Research Associates, Inc. (ARA) developed the Deposition And Response in the Respiratory Tract (DARRT) model; an improved medical model of particle size effects for inhalation hazards from chemical and biological (CB) agents. This project was initiated to improve modeling of the variation in human response caused by differences in particle sizes, in particular, for coarse particles that may be present near a dissemination source and may remain suspended long enough in an urban environment to expose large numbers of people. Plume dispersion calculations with the Defense Threat Reduction Agency's (DTRA's) Hazard Prediction and Assessment Capability (HPAC) show that, contrary to common beliefs, particles as large as 20 to 40 microns in diameter can be a significant hazard tens of kilometers downwind of a release. DARRT predicts the probability of infection or injury from inhalation exposure to aerosol hazards of CB agents with aerodynamic diameters between 0.01 and 100 microns and describes the resulting medical impact. Many current models assume that only the 1 to 5 micron respirable particles capable of reaching the pulmonary region of the respiratory system are of concern; however, we find that inclusion of coarse (greater than 5 micron) particle deposition is important, as well.
- Open Access
- 1 October 2014
- Published by Defense Technical Information Center (DTIC)
Cesium-137 Decorporation Model
A treatment model for Cs-137 internal contamination by Prussian Blue was developed to evaluate efficacy of various treatment regimens. The model estimates Cs deposition, absorption, distribution, retention, excretion, and response to DTPA after an inhalation exposure. It estimates the acute red bone marrow and whole body effective dose as a function of time. Model results compare favorably with human and animal data. Outputs from the model include Cs deposition in the respiratory tract, distribution in tissue compartments over time with and without treatment, excretion rates, and radiation doses to critical organs. Calculations from the model may be used to analyze consequences of exposure to Cs and the effect of treatment.
- 1 October 2014
- Published by Defense Technical Information Center (DTIC)
Open AccessCesium-137 Decorporation Model
A treatment model for Cs-137 internal contamination by Prussian Blue was developed to evaluate efficacy of various treatment regimens. The model estimates Cs deposition, absorption, distribution, retention, excretion, and response to DTPA after an inhalation exposure. It estimates the acute red bone marrow and whole body effective dose as a function of time. Model results compare favorably with human and animal data. Outputs from the model include Cs deposition in the respiratory tract, distribution in tissue compartments over time with and without treatment, excretion rates, and radiation doses to critical organs. Calculations from the model may be used to analyze consequences of exposure to Cs and the effect of treatment.
- Open Access
- 1 October 2014
- Published by Defense Technical Information Center (DTIC)
Plutonium 238/239 Decorporation Model
A treatment model for Pu-238/239 internal contamination by DTPA was developed to evaluate efficacy of various treatment regimens. The model estimates Pu deposition, absorption, distribution, retention, excretion, and response to DTPA after an inhalation exposure. It estimates the acute red bone marrow and lung doses and whole body effective dose as a function of time. Model results compare favorably with human and animal data. Outputs from the model include Pu deposition in the respiratory tract, distribution in tissue compartments over time with and without treatment, excretion rates, and radiation doses to critical organs. Calculations from the model may be used to analyze consequences of exposure to Pu and the effect of treatment.
- 1 October 2014
- Published by Defense Technical Information Center (DTIC)
Open AccessPlutonium 238/239 Decorporation Model
A treatment model for Pu-238/239 internal contamination by DTPA was developed to evaluate efficacy of various treatment regimens. The model estimates Pu deposition, absorption, distribution, retention, excretion, and response to DTPA after an inhalation exposure. It estimates the acute red bone marrow and lung doses and whole body effective dose as a function of time. Model results compare favorably with human and animal data. Outputs from the model include Pu deposition in the respiratory tract, distribution in tissue compartments over time with and without treatment, excretion rates, and radiation doses to critical organs. Calculations from the model may be used to analyze consequences of exposure to Pu and the effect of treatment.
- 4 January 2010
- Published by Taylor & Francis in Inhalation Toxicology
- Vol. 22 (2) , 151-159
A review of inhalability fraction models: discussion and recommendations
The first step in mathematically modeling the mechanics of respiratory deposition of particles is to estimate the ability of a particle to enter the head, either through the mouth or nose. Models of the biological effects from inhaled particles are commonly, albeit incorrectly, simplified by making an assumption that the only particles of concern are those that can readily penetrate to the pulmonary region of the lung: typically particles less than 5 μm in aerodynamic diameter. Inhalability for particles of this size is effectively 100%, so there is little need to develop a mathematical representation of the phenomenon. However, chemical irritants, biological agents, or radioactive material, in the form of large particles or droplets, can cause adverse biological responses by simply being taken into the head and depositing in the extrathoracic area. As a result, it is important to understand the inhalability of both small and large particles. The concept of particle inhalability received little consideration until the 1970s; since then it has been the subject of many experiments with a fairly wide disparity of results, in part due to the variety of dependent variables and the difficulty in adequate measurement methods. This article describes the currently utilized models of inhalability, recommends specific methods for implementing inhalability into mathematical models of respiratory deposition, and identifies outstanding issues and limitations. In this article, we describe inhalability as it applies to particulate matter and liquid droplets; modeling the inhalability of fibers is a work in progress and is not addressed.
- 4 January 2010
- Published by Taylor & Francis in Inhalation Toxicology
- Vol. 22 (2) , 151-159
A review of inhalability fraction models: discussion and recommendations
The first step in mathematically modeling the mechanics of respiratory deposition of particles is to estimate the ability of a particle to enter the head, either through the mouth or nose. Models of the biological effects from inhaled particles are commonly, albeit incorrectly, simplified by making an assumption that the only particles of concern are those that can readily penetrate to the pulmonary region of the lung: typically particles less than 5 μm in aerodynamic diameter. Inhalability for particles of this size is effectively 100%, so there is little need to develop a mathematical representation of the phenomenon. However, chemical irritants, biological agents, or radioactive material, in the form of large particles or droplets, can cause adverse biological responses by simply being taken into the head and depositing in the extrathoracic area. As a result, it is important to understand the inhalability of both small and large particles. The concept of particle inhalability received little consideration until the 1970s; since then it has been the subject of many experiments with a fairly wide disparity of results, in part due to the variety of dependent variables and the difficulty in adequate measurement methods. This article describes the currently utilized models of inhalability, recommends specific methods for implementing inhalability into mathematical models of respiratory deposition, and identifies outstanding issues and limitations. In this article, we describe inhalability as it applies to particulate matter and liquid droplets; modeling the inhalability of fibers is a work in progress and is not addressed.
- 24 June 2009
- Published by Taylor & Francis in Inhalation Toxicology
- Vol. 0 (0)
A review of inhalability fraction models: discussion and recommendations
- 24 June 2009
- Published by Taylor & Francis in Inhalation Toxicology
- Vol. 0 (0)
A review of inhalability fraction models: discussion and recommendations